Condition
Multi Drug Resistant Infections
Total Trials
2
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Tigecycline Once Daily Regimen
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 4 (1)
Trial Status
Not Yet Recruiting1
Active Not Recruiting1
Clinical Trials (2)
Research Network
Common Treatments
- Tigecycline Once Daily Regimen1
- Usual Doses Of Tigecycline1
Active Sponsors
- Air Force Specialized Hospital, Cairo, Egypt1
- Henan University of Traditional Chinese Medicine1
Top Investigators
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Related Conditions
- Pneumnia1